SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0269881107083798v1
22/7/792    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Demyttenaere, K.
Right arrow Articles by Jaspers, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demyttenaere, K.
Right arrow Articles by Jaspers, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Bupropion and SSRI–induced side effects

Koen Demyttenaere* and Liesbeth Jaspers

University Psychiatric Center KuLeuven, Campus Gasthuisberg, Herestraat 49, B–3000 Leuven, Belgium.

* To whom correspondence should be addressed.


   Abstract

Selective serotonin reuptake inhibitors (SSRIs) are a first line treatment option for millions of patients, due to the positive balance between efficacy and tolerability. However, some side effects associated with their use, can impair quality of life and compliance with treatment. This paper reviews the prevalence of sexual dysfunction, weight gain and emotional detachment during SSRI treatment, the profile of bupropion for each of these events and the ability of bupropion to reverse them. Double–blind trials, open–label trials and anecdotical reports derived from Medline were included. First, there is robust evidence that SSRIs can induce sexual side effects and that bupropion causes less sexual dysfunction than SSRIs. There is limited, mainly open–label evidence that bupropion can reverse SSRI–induced sexual side effects. Second, there is good evidence that long–term treatment with some SSRIs can result in weight gain and that long–term treatment with bupropion can result in a small weight loss. There is only anecdotical evidence that bupropion can reverse SSRIinduced weight gain. Third, treatment with SSRIs has been associated with 'emotional detachment', although controversy exists about this concept. No data are available on the profile of bupropion for 'emotional detachment' or for the reversal of SSRI–induced 'emotional detachment' by bupropion–addition.

Key Words: bupropion, serotonin reuptake inhibitors, sexual dysfunction, weight gain, emotional detachment

First published on February 28, 2008, doi:10.1177/0269881107083798

Journal of Psychopharmacology 2008;22:792.

A more recent version of this article appeared on September 1, 2008


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BMJHome page
M. Kivimaki, D. A Lawlor, A. Singh-Manoux, G D. Batty, J. E Ferrie, M. J Shipley, H. Nabi, S. Sabia, M. G Marmot, and M. Jokela
Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort study
BMJ, October 6, 2009; 339(oct06_2): b3765 - b3765.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
J Deakin and C O'Loughlin
STAR*D: a summary and UK perspective
J Psychopharmacol, August 1, 2009; 23(6): 605 - 612.
[PDF]


Home page
Br. J. PsychiatryHome page
M. Kivimaki, G. D. Batty, A. Singh-Manoux, H. Nabi, S. Sabia, A. G. Tabak, T. N. Akbaraly, J. Vahtera, M. G. Marmot, and M. Jokela
Association between common mental disorder and obesity over the adult life course
The British Journal of Psychiatry, August 1, 2009; 195(2): 149 - 155.
[Abstract] [Full Text] [PDF]



Advertisement